Medicines

The medicines sector is characterised by a few large pharmaceutical companies and a large number of SME “biotech” companies.

Support for companies of all sizes is provided by the Health Team across the sector but particularly linked with the manufacturing of pharmaceuticals and advanced therapeutics. Members of the Health Team are closely aligned with the Medicines Manufacturing Industry Partnership and the Bioindustry Association.

KTN also organises the Medicines Manufacturing Challenge Community. Its core goal is to accelerate the outcomes from the medicines manufacturing ISCF Challenge which has seen £146m invested in different projects, including the Medicines Manufacturing Innovation Centre and Advanced Therapy Treatment Centres.

Karen Wilkinson

Our Expert

Karen Wilkinson

Read full profile

Related Opportunities

SBRI: Overdose detection, response and intervention

Opens: 31/01/2023 Closes: 21/04/2023

Organisations can apply for a share of £5 million inclusive of VAT. This is to deliver innovations addressing key drug related overdose priorities across two competitions.

More Information

SBRI: Medicines and dementia phase 1

Opens: 27/02/2023 Closes: 24/05/2023

This is a Small Business Research Initiative (SBRI) competition funded by the Scottish Health Industry Partnership (SHIP). Organisations can apply for a share of up to £240,000 inclusive of VAT, to develop disruptive, innovative solutions supporting people at risk of dementia to manage their medica…

More Information

Innovate UK Smart grants: January 2023

Opens: 19/01/2023 Closes: 14/06/2023

UK registered organisations can apply for a share of up to £25 million for game-changing and commercially viable R&D innovations that can significantly impact the UK economy. The dates for this round of Smart have been extended to maximise funding opportunities for applicants.

More Information
UK Phage Innovation Showcase
16th May 2023

UK Phage Innovation Showcase

Join us at this free inaugural event for the official launch of the University of Leicester’s Centre for Phage Research and showcase of the knowledge and experience in phage research and development in the UK across multiple sectors.

Read More

Related News

New report 'The Human Intestinal Microbiome - Therapies and Diagnostics: The Science, Opportunities and Challenges' published

28/02/2023

New report 'The Human Intestinal Microbiome - Therapies and Diagnostics: The Science, Opportunities and Challenges' published

This deep dive report reviews the landscape of human gut microbiome research and innovation in the UK, focusing on the science, opportunities, and challenges of developing human intestinal microbiome therapies and diagnostics.

Read more
Innovate UK KTN Launches Phage Innovation Network

21/11/2022

Innovate UK KTN Launches Phage Innovation Network

Innovate UK KTN’s Phage Innovation Network will be instrumental in driving innovation in the regulation and development of PBTs for applications across multiple sectors.

Read more
More News

Programmes related to Medicines

Medimap: End-to-end medicines supply chain map

Medimap: End-to-end medicines supply chain map

Medimap is a new interactive reference tool for the UK medicines sector, mapping and categorising over 3,000 sites of organisations engaged in or supporting the end-to-end supply chain for medicines.

Medicines Manufacturing Challenge Community

Medicines Manufacturing Challenge Community

A now-completed programme that supported manufacturers of medicines in order to grow the UK economy – replaced by the Medicines Manufacturing programme.

Health Funding Map

Health Funding Map

The map was developed by KTN and the BioIndustry Association (BIA) with the help of a wide range of funders. It helps in the navigation of the complicated world of health innovation funding.

Close

Connect with Innovate UK KTN

Join Innovate UK KTN's mailing list to receive updates on funding opportunities, events and to access IUK KTN’s deep expertise. Please check your email to confirm your subscription and select your area(s) of interest.